Kim C D, Kim H H, Hong K W
Department of Pharmacology, College of Medicine, Pusan National University, Pusan, Korea.
J Pharmacol Exp Ther. 1999 Jan;288(1):133-8.
We investigated the mechanism or mechanisms by which rebamipide protects against the gastric mucosal inflammation associated with Helicobacter pylori. The production of interleukin (IL)-8 in association with expression of IL-8 mRNA was greatly increased in the H. pylori-infected Kato III cells in a concentration- and time-dependent manner, whereas the secretion of IL-6 and tumor necrosis factor-alpha was not detectable. The increased production of IL-8 and expression of IL-8 mRNA were significantly inhibited by rebamipide (100-1000 microM) in a concentration-dependent manner. Formyl-methionyl-leucyl-phenylalanine (1 nM), as well as conditioned medium (CM) that was produced from H. pylori-infected Kato III cells, caused an increase in surface expression of CD11b on human neutrophils and an increase in neutrophil adhesion to the human umbilical vein endothelial cells. Rebamipide also suppressed the adherence of neutrophils to endothelial cells as well as the expression of CD11b on neutrophils induced by formyl-methionyl-leucyl-phenylalanine and CM. Furthermore, CM-induced neutrophil adhesion to the endothelial cells was significantly inhibited by IL-8-neutralizing antibody, suggesting that IL-8 is implicated in the CM-induced neutrophil adhesion to the cultured human umbilical vein endothelial cells. It is concluded that rebamipide exerts its preventive effect against H. pylori-evoked gastric mucosal cell inflammation by inhibition of the neutrophil adherence to the endothelial cells as well as by suppressing the surface expression of CD11b on neutrophils and the production of proinflammatory cytokine such as IL-8 from gastric epithelial cells.
我们研究了瑞巴派特预防幽门螺杆菌相关胃黏膜炎症的一种或多种机制。在幽门螺杆菌感染的Kato III细胞中,白细胞介素(IL)-8的产生及其mRNA表达呈浓度和时间依赖性大幅增加,而未检测到IL-6和肿瘤坏死因子-α的分泌。瑞巴派特(100 - 1000 microM)以浓度依赖性方式显著抑制IL-8产生的增加及其mRNA的表达。甲酰甲硫氨酰亮氨酰苯丙氨酸(1 nM)以及幽门螺杆菌感染的Kato III细胞产生的条件培养基(CM),可导致人中性粒细胞表面CD11b表达增加以及中性粒细胞与人脐静脉内皮细胞的黏附增加。瑞巴派特还可抑制中性粒细胞与内皮细胞的黏附以及由甲酰甲硫氨酰亮氨酰苯丙氨酸和CM诱导的中性粒细胞表面CD11b的表达。此外,IL-8中和抗体可显著抑制CM诱导的中性粒细胞与内皮细胞的黏附,提示IL-8参与了CM诱导的中性粒细胞与培养的人脐静脉内皮细胞的黏附。结论是,瑞巴派特通过抑制中性粒细胞与内皮细胞的黏附、抑制中性粒细胞表面CD11b的表达以及抑制胃上皮细胞促炎细胞因子如IL-8的产生,对幽门螺杆菌诱发的胃黏膜细胞炎症发挥预防作用。